
dutrebis
Pharmaranks rates Dutrebis 3.5/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Dutrebis is a combination medicine containing Lamivudine and Raltegravir Potassium.
Lamivudine and Raltegravir Potassium · by Merck Sharp Dohme
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Lamivudine and Raltegravir Potassium
- Form
- Tablet
- Strength
- Lamivudine 150MG; Raltegravir Potassium EQ 300MG Base
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- Manufacturer
- Merck Sharp Dohme
- What the pharmacy pays
- ~$0.43 per ml — not your price
- FDA application
- NDA206510
- Availability
- Discontinued (per FDA)
Dosage forms
Tablet
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- How is Dutrebis rated?
- pharmaranks gives Dutrebis a composite score of 3.5 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- How much does Dutrebis cost?
- Nobody can tell you what you will pay — your price is set by your insurer's formulary, your deductible and the pharmacy's markup, and none of those are published. What IS published is what the pharmacy paid to acquire it: about $0.43 per ml, per the CMS NADAC survey. Treat that as the floor, not the quote — ask the pharmacist for the cash price as well as your copay, because for cheap generics the cash price often wins.
- Is there a coupon or discount for Dutrebis?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Dutrebis. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Dutrebis?
- Dutrebis is marketed by Merck Sharp Dohme. You can see Merck Sharp Dohme's full profile, rating, and other products on pharmaranks.
- Is Dutrebis a brand-name or generic drug?
- Dutrebis is a brand-name product with the active ingredient Lamivudine and Raltegravir Potassium.
- Is Dutrebis available over the counter?
- No. Dutrebis is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Dutrebis come in?
- Dutrebis is currently marketed as tablet, per the FDA's National Drug Code Directory.
- Is Dutrebis FDA-registered?
- Dutrebis is on record with the U.S. FDA under application number NDA206510. You can verify this on its official FDA label.
- Has Dutrebis been recalled by the FDA?
- Dutrebis has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Dutrebis safe?
- There's no single safe-or-not verdict. pharmaranks gives Dutrebis a recall-safety score of 70/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
Reviews
No reviews yet. Be the first to write one.
People also viewed
abiraterone acetate
Abiraterone Acetate
acular
Ketorolac Tromethamine
acular ls
Ketorolac Tromethamine
aimovig
Erenumab-Aooe
albendazole
Albendazole
alphagan p
Brimonidine Tartrate
Compare Dutrebis head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
dutrebis
70/100